Patients with kidney failure can take Metoprolol Succinate.
The full name of Metoprolol Succinate is Metoprolol Succinate Extended-Release Tablets, which is mainly used for the treatment of hypertension, angina pectoris, accompanied by left ventricular systolic function abnormalities in symptomatic stable chronic heart failure. Renal function has no significant effect on clearance, and no dosage adjustment is required in patients with renal impairment; therefore, patients with renal failure can take metoprolol succinate extended-release tablets orally.
However, metoprolol may aggravate symptoms of peripheral vascular circulatory disorders such as intermittent claudication. Caution must be exercised in severe renal impairment, various acute illnesses with metabolic acidosis, and when combining digitalis.
It is also contraindicated in patients with cardiogenic shock, sick sinus node syndrome, symptomatic bradycardia or hypotension, severe peripheral vascular disease with risk of gangrene, and hypersensitivity to any of the components of the product or other beta-blockers.
If patients with renal failure need to take metoprolol succinate extended-release tablets, it is recommended to go to a regular hospital in time, need to be used under the guidance of a doctor, avoid self-medication.